Ahn JC - Search Results

1

Transarterial radioembolization versus systemic treatment for hepatocellular carcinoma with macrovascular invasion: Analysis of the US National Cancer Database.

Ahn JC, Lauzon M, Luu M, Friedman ML, Kosari K, Nissen N, Lu SC, Roberts LR, Singal AG, Yang JD. Ahn JC, et al. J Nucl Med. 2021 Apr 9;62(12):1692-701. doi: 10.2967/jnumed.121.261954. Online ahead of print. J Nucl Med. 2021. PMID: 33837067 Free PMC article.

2

Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.

Ahn JC, Teng PC, Chen PJ, Posadas E, Tseng HR, Lu SC, Yang JD. Ahn JC, et al. Hepatology. 2021 Jan;73(1):422-436. doi: 10.1002/hep.31165. Epub 2021 Jan 18. Hepatology. 2021. PMID: 32017145 Free PMC article. Review.

3

Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.

Govalan R, Luu M, Lauzon M, Kosari K, Ahn JC, Rich NE, Nissen N, Roberts LR, Singal AG, Yang JD. Govalan R, et al. Among authors: ahn jc. Hepatol Commun. 2022 Jan;6(1):223-236. doi: 10.1002/hep4.1795. Epub 2021 Aug 25. Hepatol Commun. 2022. PMID: 34558830 Free PMC article.

4

Comparison of Surgical Resection and Systemic Treatment for Hepatocellular Carcinoma with Vascular Invasion: National Cancer Database Analysis.

Govalan R, Lauzon M, Luu M, Ahn JC, Kosari K, Todo T, Kim IK, Noureddin M, Kuo A, Walid AS, Sundaram V, Lu SC, Roberts LR, Singal AG, Heimbach JK, Agopian VG, Nissen N, Yang JD. Govalan R, et al. Among authors: ahn jc. Liver Cancer. 2021 Apr 23;10(5):407-418. doi: 10.1159/000515554. eCollection 2021 Sep. Liver Cancer. 2021. PMID: 34721504 Free PMC article.

5

Deep learning in hepatocellular carcinoma: Current status and future perspectives.

Ahn JC, Qureshi TA, Singal AG, Li D, Yang JD. Ahn JC, et al. World J Hepatol. 2021 Dec 27;13(12):2039-2051. doi: 10.4254/wjh.v13.i12.2039. World J Hepatol. 2021. PMID: 35070007 Free PMC article. Review.

6

Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.

Ahn JC, Lauzon M, Luu M, Noureddin M, Ayoub W, Kuo A, Sundaram V, Kosari K, Nissen N, Gong J, Hendifar A, Roberts LR, Abou-Alfa GK, Singal AG, Yang JD. Ahn JC, et al. Hepatology. 2022 Dec;76(6):1649-1659. doi: 10.1002/hep.32527. Epub 2022 Apr 27. Hepatology. 2022. PMID: 35429171

7

Hepatocellular carcinoma surveillance: current practice and future directions.

Ahn JC, Lee YT, Agopian VG, Zhu Y, You S, Tseng HR, Yang JD. Ahn JC, et al. Hepatoma Res. 2022;8:10. doi: 10.20517/2394-5079.2021.131. Epub 2022 Mar 11. Hepatoma Res. 2022. PMID: 36161213 Free PMC article.

8

Systemic therapy in advanced hepatocellular carcinoma.

Ahn JC, Tran NH, Yang JD. Ahn JC, et al. Clin Mol Hepatol. 2023 Apr;29(2):516-519. doi: 10.3350/cmh.2023.0051. Epub 2023 Feb 20. Clin Mol Hepatol. 2023. PMID: 36800697 Free PMC article. No abstract available.

9

Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study.

Kim S, Jeong S, Park SJ, Chang J, Choi S, Cho Y, Ahn JC, Lee G, Son JS, Park SM. Kim S, et al. Among authors: ahn jc. J Clin Med. 2022 May 19;11(10):2865. doi: 10.3390/jcm11102865. J Clin Med. 2022. PMID: 35628991 Free PMC article.

10

Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.

Sundaram V, Jalan R, Ahn JC, Charlton MR, Goldberg DS, Karvellas CJ, Noureddin M, Wong RJ. Sundaram V, et al. Among authors: ahn jc. J Hepatol. 2018 Sep;69(3):617-625. doi: 10.1016/j.jhep.2018.04.016. Epub 2018 Apr 28. J Hepatol. 2018. PMID: 29709681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page